Your search matched 45 results
Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.
Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.
A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.
With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.
Complications from drug interactions can present patients with whole new afflictions.
The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.
To retail behemoths, the health care realm is growing irresistible.
The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.
Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.
A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.
As the use of artificial intelligence in R&D continues to rise, Novartis takes it even further, equipping its reps with AI that suggests the perfect things to talk about with HCPs.
Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.
A recent proposal by the U.S.
Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.
In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.
In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.
GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.
Not your typical geotag for pharmaceutical innovation, Jackson Hole and its most prominent biologist, Paul Cox, may turn decades’ and billions of dollars’ worth of Alzheimer’s research on its head.
While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.
Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.
Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.
After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.
Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.
At this year’s Digital Medicine & MedTech Showcase (part of Biotech Showcase), a panel of digital therapeutics (DTx) experts illuminated the status and future of their work, moderated by Syneos Health Commercial Solutions Chief Strategy Officer, Baba Shetty.
With there being so many different stakeholders, including patients, providers and payers, panelists at the 2019 Digital Medicine & MedTech Showcase pointed to a number of different adoption roadblocks—and successes.
In some rooms at Cedars-Sinai Hospital, patients won’t spend a moment alone—sort of—now that the leading Beverly Hills medical center has partnered with Aiva Health to make select rooms smart.
According to the U.S.
Is the market prepared for DTx?
Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.